Edith Dufay
Overview
Explore the profile of Edith Dufay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bouet J, Potier A, Michel B, Mongaret C, Ade M, Dony A, et al.
Int J Clin Pharm
. 2024 Mar;
46(3):727-735.
PMID: 38551750
Background: Pharmaceutical decision support systems (PDSSs) use reasoning software to match patient data to modelled situations likely to cause drug-related problems (DRPs) or adverse drug events. To aid decision-making, modelled...
2.
Potier A, Ade M, Demore B, Divoux E, Dony A, Dufay E
Eur J Hosp Pharm
. 2024 Jan;
PMID: 38233119
Objectives: To evaluate the efficacy of integrating antithrombotic-focused pharmaceutical algorithms (PAs) into a pharmaceutical decision support system (PDSS) for detecting drug-related problems (DRPs) and facilitating pharmaceutical interventions. Methods: A set...
3.
Potier A, Dufay E, Dony A, Divoux E, Arnoux L, Boschetti E, et al.
Int J Med Inform
. 2022 Feb;
160:104708.
PMID: 35168091
Background: Pharmaceutical analysis of the prescription has to prop up the quality of patients' medication management in a context of medication's risk acculturation. But this activity remains highly variable. Medication-related...
4.
Herledan C, Baudouin A, Larbre V, Gahbiche A, Dufay E, Alquier I, et al.
Support Care Cancer
. 2020 Mar;
28(8):3557-3569.
PMID: 32189099
Purpose: Medication reconciliation can reduce drug-related iatrogenesis by facilitating exhaustive information transmission at care transition points. Given the vulnerability of cancer patients to adverse drug events, medication reconciliation could provide...
5.
Dufay E, Morice S, Dony A, Baum T, Doerper S, Rauss A, et al.
Eur J Hosp Pharm
. 2019 Jun;
23(4):207-212.
PMID: 31156850
Objective: This study was designed to assess the clinical impact of medication reconciliation using two criteria: the number of inpatients who had experienced at least one medication error; the severity...
6.
Potier A, Dony A, Crapsky A, Ferry O, Piney D, Dufay E
Therapie
. 2015 Aug;
70(6):541-4.
PMID: 26238127
A 62-year-old woman treated with fluvastatin experienced three separate thrombocytopenic illnesses, severe on two occasions associated with nadir platelet count of 57 000/µL and 75 000/µL. The hospital pharmacist replaced ...
7.
Doerper S, Godet J, Alexandra J, Allenet B, Andres E, Bedouch P, et al.
Eur J Intern Med
. 2015 Jul;
26(7):491-7.
PMID: 26209101
Background: Medication reconciliation is a powerful process to correct medication errors (ME) resulting from miscommunicated information at transitions of care. This study aims to develop and evaluate a scoring method...
8.
[Angiotensin-converting enzyme inhibitors in congestive heart failure: clinical practice guidelines]
Thilly N, Zannad F, Dufay E, Juilliere Y, Briancon S
Therapie
. 2003 Dec;
58(4):341-9.
PMID: 14679673
Angiotensin-converting enzyme (ACE) inhibitors are, at present, the cornerstone of therapy for congestive heart failure. Nevertheless, international literature and regional data have reported their underutilisation in the practice of cardiology....
9.
Thilly N, Briancon S, Juilliere Y, Dufay E, Zannad F
J Eval Clin Pract
. 2003 Aug;
9(3):373-82.
PMID: 12895159
Rationale, Aims And Objectives: The efficacy of angiotensin-converting enzyme (ACE) inhibitors in treating heart failure is well established, but there is concern that these agents are underutilized. This study aimed...